Dextera Surgical Inc. (NASDAQ:DXTR) – Equities researchers at Wedbush dropped their FY2018 earnings estimates for shares of Dextera Surgical in a note issued to investors on Tuesday. Wedbush analyst Levy. T now expects that the medical instruments supplier will post earnings per share of ($0.21) for the year, down from their previous forecast of ($0.20). Wedbush has a “Outperform” rating and a $0.70 price target on the stock. Wedbush also issued estimates for Dextera Surgical’s FY2019 earnings at ($0.22) EPS.

Dextera Surgical (NASDAQ:DXTR) last released its quarterly earnings data on Tuesday, August 8th. The medical instruments supplier reported ($0.40) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.11) by ($0.29). The firm had revenue of $1.05 million during the quarter, compared to the consensus estimate of $1.03 million.

WARNING: “Brokers Set Expectations for Dextera Surgical Inc.’s FY2018 Earnings (DXTR)” was published by American Banking News and is owned by of American Banking News. If you are viewing this piece of content on another site, it was copied illegally and republished in violation of U.S. and international copyright and trademark legislation. The original version of this piece of content can be viewed at

A number of other analysts also recently weighed in on the company. Zacks Investment Research upgraded Dextera Surgical from a “strong sell” rating to a “hold” rating in a research report on Tuesday. Ladenburg Thalmann Financial Services assumed coverage on Dextera Surgical in a research report on Wednesday, August 16th. They issued a “buy” rating and a $0.80 target price for the company.

Dextera Surgical (NASDAQ:DXTR) traded down 6.6383% on Thursday, hitting $0.2194. The stock had a trading volume of 1,450,386 shares. Dextera Surgical has a 1-year low of $0.17 and a 1-year high of $2.33. The stock’s market capitalization is $3.90 million. The company has a 50-day moving average price of $0.30 and a 200-day moving average price of $0.41.

A number of large investors have recently added to or reduced their stakes in DXTR. Perkins Capital Management Inc. bought a new stake in Dextera Surgical in the 2nd quarter worth approximately $100,000. Virtu KCG Holdings LLC increased its stake in Dextera Surgical by 1,380.6% in the 2nd quarter. Virtu KCG Holdings LLC now owns 369,918 shares of the medical instruments supplier’s stock worth $111,000 after purchasing an additional 344,933 shares during the period. Finally, Broadfin Capital LLC increased its stake in Dextera Surgical by 64.7% in the 2nd quarter. Broadfin Capital LLC now owns 987,520 shares of the medical instruments supplier’s stock worth $296,000 after purchasing an additional 388,080 shares during the period. Institutional investors own 6.58% of the company’s stock.

Dextera Surgical Company Profile

Dextera Surgical Inc, formerly Cardica, Inc, designs and manufactures stapling devices that enable the advancement of minimally invasive surgical procedures. The Company is engaged in commercializing and developing its MicroCutter 5/80 stapler based on its staple-on-a-strip technology for use by thoracic, pediatric, bariatric, colorectal and general surgeons.

Earnings History and Estimates for Dextera Surgical (NASDAQ:DXTR)

Receive News & Ratings for Dextera Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dextera Surgical Inc. and related companies with's FREE daily email newsletter.